Literature DB >> 21208589

Major depressive disorder is associated with cardiovascular risk factors and low Omega-3 Index.

Thomas C Baghai1, Gabriella Varallo-Bedarida, Christoph Born, Sibylle Häfner, Cornelius Schüle, Daniela Eser, Rainer Rupprecht, Brigitta Bondy, Clemens von Schacky.   

Abstract

OBJECTIVE: Cardiovascular disease (CVD) and major depressive disorder (MDD) are frequent worldwide and have a high comorbidity rate. Omega-3 fatty acids have been suggested as disease modulators for both CVD and MDD. Therefore, we studied whether polyunsaturated fatty acids and the Omega-3 Index may represent markers for assessment of the cardiovascular risk in somatically healthy patients suffering from MDD.
METHOD: We conducted a case-control study from July 2004 to December 2007 in 166 adults (86 inpatients with MDD but without CVD from the Department of Psychiatry and Psychotherapy and 80 age- and sex-matched healthy controls from an outpatient clinic of the Division of Preventive Cardiology, Ludwig Maximilian University of Munich, Germany). Information gathered at baseline included MDD diagnosis according to DSM-IV criteria, depression ratings, conventional cardiovascular risk factors, and fatty acid and interleukin-6 determinations. Fatty acid composition was analyzed according to the HS-Omega-3 Index methodology. During the study, patients received no supplementation with omega-3 fatty acids. The main inclusion criteria were the diagnosis of MDD according to DSM-IV and a 17-item Hamilton Depression Rating Scale (HDRS-17) score of at least 17. Treatment response and remission were defined using the HDRS-17.
RESULTS: Several conventional risk factors such as high triglyceride (mean, 152 mg/dL vs 100 mg/dL; P < .001) and fasting glucose (mean, 96 mg/dL vs 87 mg/dL; P = .005) values as well as greater waist circumference (mean, 97 cm vs 87 cm; P = .019) and higher body mass index (calculated as kg/m(2); mean, 26 vs 24; P = .011) were more prevalent in MDD patients in comparison with controls. The Omega-3 Index (mean, 3.9% vs 5.1%; P < .001) and individual omega-3 fatty acids were significantly lower in MDD patients. An Omega-3 Index < 4% was associated with high concentrations of the proinflammatory cytokine interleukin-6 (χ(2) = 7.8, P = .02).
CONCLUSIONS: Conventional cardiovascular risk factors, the Omega-3 Index, and interleukin-6 levels indicated an elevated cardiovascular risk profile in MDD patients currently free of CVD. Our results support the employment of strategies to reduce the cardiovascular risk in still cardiovascularly healthy MDD patients by targeting conventional risk factors and the Omega-3 Index. © Copyright 2011 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21208589     DOI: 10.4088/JCP.09m05895blu

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  22 in total

1.  Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study.

Authors:  William S Harris; James V Pottala; Sean M Lacey; Ramachandran S Vasan; Martin G Larson; Sander J Robins
Journal:  Atherosclerosis       Date:  2012-06-07       Impact factor: 5.162

Review 2.  Emerging risk biomarkers in cardiovascular diseases and disorders.

Authors:  Ravi Kant Upadhyay
Journal:  J Lipids       Date:  2015-04-08

3.  Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteers.

Authors:  Alison H Keenan; Theresa L Pedersen; Kristi Fillaus; Mark K Larson; Gregory C Shearer; John W Newman
Journal:  J Lipid Res       Date:  2012-05-24       Impact factor: 5.922

Review 4.  Polyunsaturated fatty acids and recurrent mood disorders: Phenomenology, mechanisms, and clinical application.

Authors:  Erik Messamore; Daniel M Almeida; Ronald J Jandacek; Robert K McNamara
Journal:  Prog Lipid Res       Date:  2017-01-06       Impact factor: 16.195

5.  Genetic Variants of the FADS Gene Cluster Are Associated with Erythrocyte Membrane LC PUFA Levels in Patients with Mild Cognitive Impairment.

Authors:  J P Schuchardt; T Köbe; V Witte; J Willers; A Gingrich; V Tesky; J Pantel; D Rujescu; T Illig; A Flöel; A Hahn
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

6.  Omega-3 fatty acid biomarkers and subsequent depressive symptoms.

Authors:  Jane E Persons; Jennifer G Robinson; Eric M Ammann; William H Coryell; Mark A Espeland; William S Harris; JoAnn E Manson; Jess G Fiedorowicz
Journal:  Int J Geriatr Psychiatry       Date:  2013-12-11       Impact factor: 3.485

7.  Low- and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome.

Authors:  Antonella Dewell; Farshad Fani Marvasti; William S Harris; Philip Tsao; Christopher D Gardner
Journal:  J Nutr       Date:  2011-10-26       Impact factor: 4.798

8.  Omega-3 fatty acid deficiency increases stearoyl-CoA desaturase expression and activity indices in rat liver: positive association with non-fasting plasma triglyceride levels.

Authors:  Rylon Hofacer; I Jack Magrisso; Ronald Jandacek; Therese Rider; Patrick Tso; Stephen C Benoit; Robert K McNamara
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-11-01       Impact factor: 4.006

9.  Omega-3 Index and Obstructive Sleep Apnea: A Cross-Sectional Study.

Authors:  Janine Tittus; Marie Theres Huber; Klaus Storck; Anton Köhler; Jan M Köhler; Thomas von Arnim; Clemens von Schacky
Journal:  J Clin Sleep Med       Date:  2017-10-15       Impact factor: 4.062

10.  Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice.

Authors:  Robert K McNamara; Jeffrey R Strawn
Journal:  PharmaNutrition       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.